Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Okta, Inc (OKTA)
-
DOMO (DOMO) PT Raised to $17 at Cantor Fitzgerald
-
DOMO (DOMO) PT Raised to Street High $17 at Cantor Fitzgerald
-
US banks tiptoe toward crypto, awaiting more green lights from regulators
-
Cantor Fitzgerald Reiterates Overweight Rating on Okta, Inc (OKTA)
-
Cantor Fitzgerald Pounding Table on NeuroPace Inc (NPCE): 'we would be buyers of NPCE on today's pullback'
-
Cantor Fitzgerald to Move 50 Alternative Investment Funds to the LODAS Transfer Agent Platform
-
Cantor Fitzgerald Reiterates Neutral Rating on Alphabet (GOOGL)
-
Trump Media to raise $2.5 billion to invest in bitcoin
-
Cantor Fitzgerald Reiterates Neutral Rating on Marvell (MRVL)
-
Cantor Fitzgerald Reiterates Overweight Rating on NVIDIA (NVDA)
-
Tether Co-Founder Reeve Collins and CC Capital Affiliate Purchase Sponsor Interests in SPAC (MBAVU) to Acquire Digital Assets
-
Tether Co-Founder Reeve Collins and CC Capital Affiliate Purchase Sponsor Interests in SPAC to Acquire Digital Assets
-
Cantor Fitzgerald Reiterates Neutral Rating on Elastic NV. (ESTC)
-
Trump Media & Technology Group (DJT) Announces $2.5B BTC Treasury Deal
-
Trump Media Announces Approximately $2.5 Billion Bitcoin Treasury Deal
-
Cantor Fitzgerald Reiterates Overweight Rating on Aurora Innovation Inc (AUR)
-
Strive Asset Management and Asset Entities (Nasdaq: ASST) Announce $750M Private Investment to Fund First Wave of Bitcoin Accumulation
-
Cantor’s Bitcoin Financing Business Fully Operational; Executes Initial Trades Throughout May
-
Cantor Fitzgerald Reiterates Overweight Rating on Tesla (TSLA)
-
Cantor Fitzgerald Reiterates Overweight Rating on Metsera Inc (MTSR)
-
Cantor Fitzgerald Downgrades Prothena Corp (PRTA) to Neutral
-
Trilogy Metals Enters Into At-The-Market Equity Distribution Agreement
-
Zscaler (ZS) PT Raised to $275 at Cantor Fitzgerald
-
Cantor Fitzgerald says CMS' new audit strategy has logistical challenges
-
Cantor Fitzgerald Reiterates Neutral Rating on Seagate Technology (STX)
-
Cantor Fitzgerald Reiterates Neutral Rating on Analog Devices (ADI)
-
Cantor Fitzgerald Reiterates Overweight Rating on Kura Oncology (KURA)
-
Cantor Fitzgerald Reiterates Overweight Rating on Microsoft (MSFT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)
-
Cantor Fitzgerald Reiterates Overweight Rating on SentinelOne Inc (S)
-
Cantor Fitzgerald Reiterates Overweight Rating on Zealand Pharma A/S (ZEAL)
-
Cantor Fitzgerald Reiterates Overweight Rating on Soleno Therapeutics Inc. (SLNO)
-
Cantor Fitzgerald Reiterates Overweight Rating on Wix.com (WIX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Proto Labs (PRLB)
-
DOMO (DOMO) PT Raised to $12 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Zoom Technologies (ZOOM)
-
Snowflake Inc. (SNOW) PT Raised to $242 at Cantor Fitzgerald
-
ORIC Pharmaceuticals Inc. (ORIC) Shares Continue Strength Follow Y'Day Sell side Comments, +6pct
-
Cantor Fitzgerald Reiterates Overweight Rating on Palo Alto Networks (PANW)
-
Cantor Fitzgerald Reiterates Overweight Rating on Okta, Inc (OKTA)
-
HCA Healthcare Inc (HCA) PT Raised to $444 at Cantor Fitzgerald
-
Cantor Fitzgerald on NVIDIA (NVDA): 'shares remain a TOP PICK'
-
Cantor Fitzgerald Reiterates Overweight Rating on ORIC Pharamceuticals (ORIC)
-
Cantor Fitzgerald Reiterates Overweight Rating on SES AI Corp. (SES)
-
Cantor Fitzgerald Reiterates Overweight Rating on Celldex Therapeutics (CLDX)
-
Cantor Fitzgerald Reiterates Neutral Rating on ViaSat (VSAT)
-
Cantor Fitzgerald Reiterates Neutral Rating on Pfizer (PFE)
-
Wen Acquisition Corp Completes $300,150,000 Initial Public Offering

